AbbVie (ABBV) Net Margin (2012 - 2026)

AbbVie has disclosed Net Margin across 15 years of filings, most recently posting 4.65% for Q1 2026.

• In Q1 2026, Net Margin fell 501.0% year-over-year to 4.65%; the TTM figure through Mar 2026 stood at 5.8% (down 153.0% YoY), while the FY2025 annual figure was 6.92%, down 69.0% from the prior year.
• Net Margin fell to 4.65% in Q1 2026, from 10.92% in the prior quarter.
• Over the last five years, Net Margin for ABBV reached as high as 33.19% in Q1 2022 and fell as low as 0.79% in Q1 2023.
• The 5-year median for Net Margin is 9.66% (2025), against an average of 10.52%.
• Annual changes were most pronounced in 2023 — Net Margin slumped 3398 bps — and 2024, when it surged 1194 bps.
• A 5-year view of Net Margin shows it stood at 16.35% in 2022, then tumbled by 65 bps to 5.76% in 2023, then sank by 103 bps to 0.15% in 2024, then jumped by 7271 bps to 10.92% in 2025, then tumbled by 57 bps to 4.65% in 2026.
• According to Business Quant data, Net Margin over the past three periods registered 4.65%, 10.92%, and 1.19% for Q1 2026, Q4 2025, and Q3 2025 respectively.